Free Trial

UCB (UCBJY) Insider Trading & Ownership

UCB logo
$150.25 +1.32 (+0.88%)
As of 10/13/2025 03:50 PM Eastern

There is no recent insider trading on record for UCB, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get UCBJY Insider Trade Alerts

Want to know when executives and insiders are buying or selling UCB stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UCB Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
9/23/2025Val T. HoyleU.S. Congress Member (D-OR)Sell$120.81$1,001 - $15,000
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$43.21$1,001 - $15,000
2/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$43.60$1,001 - $15,000
(Data available from 1/1/2013 forward)

UCBJY Insider Trading Activity - Frequently Asked Questions

Val T. Hoyle (D-OR) has sold shares of UCB in the last year totaling $8,000.

UCB Key Executives

  • Mr. Jean-Christophe Tellier (Age 65)
    CEO & Executive Director
    Compensation: $4.46M
  • Ms. Sandrine Dufour CFA (Age 58)
    Executive VP, CFO & Chief Corporate Development
  • Dr. Kirsten Lund-Jurgensen Ph.D. (Age 64)
    Executive Vice President of Supply & Technology Solutions
  • Ms. Denelle J. Waynick Johnson J.D. (Age 57)
    Executive VP & General Counsel
  • Mr. Jean-Luc Fleurial (Age 59)
    Executive VP & Chief Human Resources Officer
  • Prof. Iris Loew-Friedrich (Age 64)
    Executive VP & Chief Medical Officer
  • Mr. Emmanuel Caeymaex (Age 55)
    Executive VP & Chief Commercial Officer
  • Ms. Fiona du Monceau (Age 46)
    Executive Vice President of Patient Evidence
    Compensation: $178.32k
  • Ms. Caroline Vancoillie
    Chief Accounting Officer, Head of Group Finance & CFO of Patient Value Functions
  • Mr. Alistair Henry (Age 57)
    Executive VP & Chief Scientific Officer


This page (OTCMKTS:UCBJY) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners